title: Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.
abstract: We report a 67-year-old Caucasian man with a long-term history of recalcitrant plaque psoriasis and psoriatic arthritis who was initiated on a treatment regimen of apremilast and secukinumab after failing multiple topical, photo, and systemic therapies. This combination provided significant skin improvement with minimal drug side effects. <br /><br /> <em>J Drugs Dermatol. </em>2016;15(5):648-649.
authors.forename: Brooke E
authors.initials: BE
authors.lastname: Rothstein
authors.forename: Brianna
authors.initials: B
authors.lastname: McQuade
authors.forename: Jacqueline E
authors.initials: JE
authors.lastname: Greb
authors.forename: Ari M
authors.initials: AM
authors.lastname: Goldminz
authors.forename: Alice B
authors.initials: AB
authors.lastname: Gottlieb
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000175:diagnosis* / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D013792:Thalidomide; C555450:secukinumab; C505730:apremilast